Alpha DNA Investment Management’s ConocoPhillips COP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-9,357
Closed -$928K 47
2024
Q4
$928K Sell
9,357
-12
-0.1% -$1.27K 0.35% 56
2024
Q3
$986K Sell
9,369
-7,058
-43% -$775K 0.37% 56
2024
Q2
$1.88M Buy
16,427
+7,490
+84% +$910K 0.73% 31
2024
Q1
$1.14M Sell
8,937
-5,439
-38% -$620K 0.42% 41
2023
Q4
$1.67M Buy
14,376
+4,953
+53% +$579K 0.65% 32
2023
Q3
$1.13M Sell
9,423
-676
-7% -$78.5K 0.46% 41
2023
Q2
$1.05M Buy
10,099
+1,483
+17% +$152K 0.35% 64
2023
Q1
$855K Sell
8,616
-7,116
-45% -$779K 0.25% 133
2022
Q4
$1.86M Buy
15,732
+2,870
+22% +$349K 0.66% 18
2022
Q3
$1.32M Buy
+12,862
New +$1.28M 1.09% 16
2021
Q2
Sell
-79
Closed -$4K 209
2021
Q1
$4K Buy
79
+72
+1,029% +$3.55K ﹤0.01% 398
2020
Q4
$0 Buy
+7
New +$258 ﹤0.01% 597

Other funds holding COP

Alpha DNA Investment Management's COP Position: Q1 2025 in Review

Alpha DNA Investment Management sold out of ConocoPhillips (COP) in Q1 2025, closing a stake of 9,357 shares — an estimated $928K sold.

Alpha DNA Investment Management first reported a position in COP in Q4 2020 and held it in 12 quarters. The position peaked at $1.88M in Q2 2024. 2,394 funds tracked by Wall St. Rank hold COP as of Q1 2025.

  • Alpha DNA Investment Management reported no remaining ConocoPhillips position as of Q1 2025 after selling out during the quarter.
  • Alpha DNA Investment Management sold 9,357 ConocoPhillips shares in Q1 2025, an estimated $928K.
  • Alpha DNA Investment Management first reported a position in ConocoPhillips in Q4 2020 and held it in 12 quarters.
  • Alpha DNA Investment Management's ConocoPhillips position peaked at $1.88M in Q2 2024.
  • 2,394 funds tracked by Wall St. Rank held ConocoPhillips as of Q1 2025.

Based on Alpha DNA Investment Management's 13F filing for Q1 2025, filed 19 May 2025.